These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10498215)

  • 1. New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D2 template.
    Mewshaw RE; Nelson JA; Shah US; Shi X; Mazandarani H; Coupet J; Marquis K; Brennan JA; Andree TH
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2593-8. PubMed ID: 10498215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation dopaminergic agents. 5. Heterocyclic bioisosteres that exploit the 3-OH-N1-phenylpiperazine dopaminergic template.
    Mewshaw RE; Verwijs A; Shi X; McGaughey GB; Nelson JA; Mazandarani H; Brennan JA; Marquis KL; Coupet J; Andree TH
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2675-80. PubMed ID: 9873601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
    Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S; Soskić V; Joksimović J
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed dopaminergic/serotonergic properties of several 2-substituted 4-[2-(5-benzimidazole)ethyl]-1-arylpiperazines.
    Kostic-Rajacic S; Soskic V; Joksimovic J
    Arch Pharm (Weinheim); 1998 Jan; 331(1):22-6. PubMed ID: 9507698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation dopaminergic agents. Part 8: heterocyclic bioisosteres that exploit the 7-OH-2-(aminomethyl)chroman D(2) template.
    Mewshaw RE; Zhao R; Shi X; Marquis K; Brennan JA; Mazandarani H; Coupet J; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):271-4. PubMed ID: 11814775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
    Dragović D; Soskić V; Joksimović J
    Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans.
    Mewshaw RE; Kavanagh J; Stack G; Marquis KL; Shi X; Kagan MZ; Webb MB; Katz AH; Park A; Kang YH; Abou-Gharbia M; Scerni R; Wasik T; Cortes-Burgos L; Spangler T; Brennan JA; Piesla M; Mazandarani H; Cockett MI; Ochalski R; Coupet J; Andree TH
    J Med Chem; 1997 Dec; 40(26):4235-56. PubMed ID: 9435894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopaminergic activity of heterocyclic analogues of 5,6-dihydroxy-2-aminotetralins.
    Bosch J; Roca T; Pérez CG; Montanari S
    Bioorg Med Chem Lett; 2000 Mar; 10(6):563-6. PubMed ID: 10741554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and dopamine D2-like receptor binding affinity of substituted 5-phenyl-pyrrole-3-carboxamides.
    Pinna GA; Curzu MM; Sechi M; Chelucci G; Maciocco E
    Farmaco; 1999 Aug; 54(8):542-50. PubMed ID: 10510851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and dopaminergic properties of 3- and 4-substituted 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]piperidines and related compounds.
    Dukic S; Kostic-Rajacic S; Soskic V; Joksimovic J
    Arch Pharm (Weinheim); 1997; 330(1-2):25-8. PubMed ID: 9112811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New generation dopaminergic agents. 6. Structure-activity relationship studies of a series of 4-(aminoethoxy)indole and 4-(aminoethoxy)indolone derivatives based on the newly discovered 3-hydroxyphenoxyethylamine D2 template.
    Mewshaw RE; Webb MB; Marquis KL; McGaughey GB; Shi X; Wasik T; Scerni R; Brennan JA; Andree TH
    J Med Chem; 1999 Jun; 42(11):2007-20. PubMed ID: 10354409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationships.
    Glase SA; Akunne HC; Heffner TG; Jaen JC; MacKenzie RG; Meltzer LT; Pugsley TA; Smith SJ; Wise LD
    J Med Chem; 1996 Aug; 39(16):3179-87. PubMed ID: 8759640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and properties of several heterocyclic dopaminergic ligands.
    Kostić S; Soskić V; Joksimović J
    Arzneimittelforschung; 1994 Jun; 44(6):697-702. PubMed ID: 7914413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and dopaminergic activity of pyridine analogs of 5-hydroxy-2-(di-n-propylamino)tetralin.
    Glase SA; Corbin AE; Pugsley TA; Heffner TG; Wise LD
    J Med Chem; 1995 Aug; 38(16):3132-7. PubMed ID: 7636875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of dopaminergic N-alkyl-benzyltetrahydroisoquinolines using a 'one-pot' procedure in acid medium.
    Andreu I; Cortes D; Protais P; Cassels BK; Chagraoui A; Cabedo N
    Bioorg Med Chem; 2000 May; 8(5):889-95. PubMed ID: 10882001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents.
    Fernández C; Nieto O; Rivas E; Montenegro G; Fontenla JA; Fernández-Mayoralas A
    Carbohydr Res; 2000 Aug; 327(4):353-65. PubMed ID: 10990020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
    Ferré S; Giménez-Llort L; Artigas F; Martínez E
    Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.